NCT06643832 is a NA clinical trial of Rubbing Distraction in Propofol Injection, sponsored by Tanta University.

Who is sponsoring NCT06643832?

NCT06643832 is sponsored by Tanta University.

What drugs are being tested in NCT06643832?

Interventions in NCT06643832: Rubbing Distraction, Lidocaine (drug), Saline.

What condition does NCT06643832 study?

NCT06643832 studies Propofol Injection, Pain, Rubbing, Distraction.

Is NCT06643832 still recruiting?

NCT06643832 is currently completed. Last updated 18 February 2025.

Last reviewed 2025-02-18 · How we verify

NCT06643832

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Modulation of Propofol Injection Pain by Rubbing and Distraction

Completed NA Last updated 18 February 2025

What this trial tests

NA trial testing Rubbing Distraction in Propofol Injection in 135 participants. Completed in 17 February 2025.

Timeline

16 October 2024

Primary endpoint
17 February 2025

17 February 2025

Quick facts

Lead sponsor	Tanta University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	135
Start date	16 October 2024
Primary completion	17 February 2025
Estimated completion	17 February 2025
Sites	1 location across Egypt

Drugs / interventions tested

Rubbing Distraction
Lidocaine (drug) — full drug profile →
Saline

Conditions studied

Propofol Injection — all drugs for Propofol Injection →
Pain — all drugs for Pain →
Rubbing — all drugs for Rubbing →
Distraction — all drugs for Distraction →

Sponsor

Tanta University

Who can join

Adults 18 to 65, any sex, with Propofol Injection or Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective randomized controlled study will be conducted to evaluate the effects of rubbing and distraction on the incidence and severity of propofol injection pain and compare them with the standard intravenous lidocaine method.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Tanta University trials

Trials by the same sponsor.

NCT07398651 — Apremilast and Adalimumab in Psoriatic Arthritis Patients · NA · not yet recruiting
NCT06966856 — This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcti · Phase 3 · not yet recruiting
NCT07334197 — Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy · NA · not yet recruiting
NCT07498998 — Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome · NA · not yet recruiting
NCT07114250 — Comparative Study Between Spinal Anesthesia Versus General Anesthesia in Supine Percutaneous Nephrolithotomy Operation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06643832 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tanta University
Last refreshed: 18 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06643832.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing